Auro Laboratories Schedules Board Meeting for Q2 FY27 Financial Results
Auro Laboratories Ltd 路 Intimation 路 13 Nov 2026, 5:30 am
Auro Laboratories Schedules Board Meeting for Q2 FY27 Financial Results Auro Laboratories Limited has scheduled a Board of Directors meeting on 13th Nov'26 to consider and approve the unaudited financial results, along with the Limited Review Report, for the quarter and half-year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for designated persons and their immediate relatives will remain closed until 48 hours after the conclusion of the board meeting.
Original exchange filing (PDF)
More announcements from Auro Laboratories Ltd
- Auro Laboratories Limited has submitted Unaudited Financial Results for the quarter and half year ended September 30, 2026. 路 14 Nov 2026
- Auro Laboratories Limited has submitted the outcome of the Board Meeting dated November 13, 2026. 路 13 Nov 2026
- Auro Laboratories Limited has submitted the Unaudited Financial Results for the Quarter ended June 30, 2026. 路 15 Aug 2026
- Auro Laboratories Limited has submitted the Outcome of the Board Meeting held on August 14, 2026 路 15 Aug 2026
- Auro Laboratories Limited has submitted the Scrutinizer Report of 37th AGM held on August 11, 2026. 路 14 Aug 2026
- Auro Laboratories Limited has submitted the Proceedings/Outcome of the 37th Annual General Meeting held on August 11, 2026. 路 12 Aug 2026
- Auro Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Unaudited Financial Results .... 路 14 Aug 2026
- The Letter being send to the shareholders containing the web-link of the Annual Report of the Company for the FY 2025-2026 is enclosed. 路 17 Jul 2026
